{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T04:21:56Z","timestamp":1794975716461,"version":"4.9.1"},"reference-count":232,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Drug Discov"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1038\/s41573-022-00470-y","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T06:04:08Z","timestamp":1654063448000},"page":"601-620","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":474,"title":["Drugging the efferocytosis process: concepts and opportunities"],"prefix":"10.1038","volume":"21","author":[{"given":"Parul","family":"Mehrotra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9049-1410","authenticated-orcid":false,"given":"Kodi S.","family":"Ravichandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,1]]},"reference":[{"key":"470_CR1","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41580-020-0232-1","volume":"21","author":"E Boada-Romero","year":"2020","unstructured":"Boada-Romero, E., Martinez, J., Heckmann, B. L. & Green, D. R. The clearance of dead cells by efferocytosis. Nat. Rev. Mol. Cell Biol. 21, 398\u2013414 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"470_CR2","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/cdd.2015.172","volume":"23","author":"D Green","year":"2016","unstructured":"Green, D., Oguin, T. & Martinez, J. The clearance of dying cells: table for two. Cell Death Differ. 23, 915\u2013926 (2016).","journal-title":"Cell Death Differ."},{"key":"470_CR3","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.immuni.2019.04.018","volume":"50","author":"S Morioka","year":"2019","unstructured":"Morioka, S., Mauer\u00f6der, C. & Ravichandran, K. S. Living on the edge: efferocytosis at the interface of homeostasis and pathology. Immunity 50, 1149\u20131162 (2019). This work details the tissue-specific aspects of efferocytosis and the pathological implications of aberrant efferocytosis.","journal-title":"Immunity"},{"key":"470_CR4","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41577-019-0240-6","volume":"20","author":"AC Doran","year":"2019","unstructured":"Doran, A. C., Yurdagul, A. & Tabas, I. Efferocytosis in health and disease. Nat. Rev. Immunol. 20, 254\u2013267 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"470_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1146\/annurev-cellbio-111315-125315","volume":"33","author":"PM Henson","year":"2017","unstructured":"Henson, P. M. Cell removal: efferocytosis. Annu. Rev. Cell Devel. Biol. 33, 127\u2013144 (2017).","journal-title":"Annu. Rev. Cell Devel. Biol."},{"key":"470_CR6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S1097-2765(04)00237-0","volume":"14","author":"K Lauber","year":"2004","unstructured":"Lauber, K., Blumenthal, S. G., Waibel, M. & Wesselborg, S. Clearance of apoptotic cells: getting rid of the corpses. Mol. Cell 14, 277\u2013287 (2004).","journal-title":"Mol. Cell"},{"key":"470_CR7","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/ni.3253","volume":"16","author":"S Arandjelovic","year":"2015","unstructured":"Arandjelovic, S. & Ravichandran, K. S. Phagocytosis of apoptotic cells in homeostasis. Nat. Immunol. 16, 907 (2015).","journal-title":"Nat. Immunol."},{"key":"470_CR8","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nature14191","volume":"517","author":"M Pasparakis","year":"2015","unstructured":"Pasparakis, M. & Vandenabeele, P. Necroptosis and its role in inflammation. Nature 517, 311\u2013320 (2015).","journal-title":"Nature"},{"key":"470_CR9","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/nature08296","volume":"461","author":"MR Elliott","year":"2009","unstructured":"Elliott, M. R. et al. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 461, 282\u2013286 (2009).","journal-title":"Nature"},{"key":"470_CR10","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/nature09413","volume":"467","author":"FB Chekeni","year":"2010","unstructured":"Chekeni, F. B. et al. Pannexin 1 channels mediate \u2018find-me\u2019 signal release and membrane permeability during apoptosis. Nature 467, 863\u2013867 (2010).","journal-title":"Nature"},{"key":"470_CR11","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0092-8674(03)00422-7","volume":"113","author":"K Lauber","year":"2003","unstructured":"Lauber, K. et al. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 113, 717\u2013730 (2003).","journal-title":"Cell"},{"key":"470_CR12","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1096\/fj.08-107169","volume":"22","author":"DR Gude","year":"2008","unstructured":"Gude, D. R. et al. Apoptosis induces expression of sphingosine kinase 1 to release sphingosine-1-phosphate as a \u201ccome-and-get-me\u201d signal. FASEB J. 22, 2629\u20132638 (2008).","journal-title":"FASEB J."},{"key":"470_CR13","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.1182\/blood-2008-06-162404","volume":"112","author":"LA Truman","year":"2008","unstructured":"Truman, L. A. et al. CX3CL1\/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis. Blood 112, 5026\u20135036 (2008).","journal-title":"Blood"},{"key":"470_CR14","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/cdd.2016.13","volume":"23","author":"CB Medina","year":"2016","unstructured":"Medina, C. B. & Ravichandran, K. S. Do not let death do us part: \u2018find-me\u2019 signals in communication between dying cells and the phagocytes. Cell Death Differ. 23, 979\u2013989 (2016).","journal-title":"Cell Death Differ."},{"key":"470_CR15","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41586-020-2121-3","volume":"580","author":"CB Medina","year":"2020","unstructured":"Medina, C. B. et al. Metabolites released from apoptotic cells act as tissue messengers. Nature 580, 130\u2013135 (2020). This study details the release of signalling metabolites from apoptotic cells and highlights the induction of anti-inflammatory and pro-resolution associated gene expression in the tissue neighbourhood.","journal-title":"Nature"},{"key":"470_CR16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.devcel.2016.06.029","volume":"38","author":"MR Elliott","year":"2016","unstructured":"Elliott, M. R. & Ravichandran, K. S. The dynamics of apoptotic cell clearance. Dev. Cell 38, 147\u2013160 (2016).","journal-title":"Dev. Cell"},{"key":"470_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imbio.2010.03.010","volume":"216","author":"C Marques-da-Silva","year":"2011","unstructured":"Marques-da-Silva, C., Burnstock, G., Ojcius, D. M. & Coutinho-Silva, R. Purinergic receptor agonists modulate phagocytosis and clearance of apoptotic cells in macrophages. Immunobiology 216, 1\u201311 (2011).","journal-title":"Immunobiology"},{"key":"470_CR18","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.02172","volume":"3","author":"H Yamaguchi","year":"2014","unstructured":"Yamaguchi, H., Maruyama, T., Urade, Y. & Nagata, S. Immunosuppression via adenosine receptor activation by adenosine monophosphate released from apoptotic cells. eLife 3, e02172 (2014).","journal-title":"eLife"},{"key":"470_CR19","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.4049\/jimmunol.1601520","volume":"198","author":"MR Elliott","year":"2017","unstructured":"Elliott, M. R., Koster, K. M. & Murphy, P. S. Efferocytosis signaling in the regulation of macrophage inflammatory responses. J. Immunol. 198, 1387\u20131394 (2017).","journal-title":"J. Immunol."},{"key":"470_CR20","doi-asserted-by":"publisher","first-page":"7144","DOI":"10.4049\/jimmunol.1002284","volume":"186","author":"K K\u00f6r\u00f6sk\u00e9nyi","year":"2011","unstructured":"K\u00f6r\u00f6sk\u00e9nyi, K. et al. Involvement of adenosine A2A receptors in engulfment-dependent apoptotic cell suppression of inflammation. J. Immunol. 186, 7144\u20137155 (2011).","journal-title":"J. Immunol."},{"key":"470_CR21","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/j.immuni.2021.06.014","volume":"54","author":"CB Medina","year":"2021","unstructured":"Medina, C. B. et al. Pannexin 1 channels facilitate communication between T cells to restrict the severity of airway inflammation. Immunity 54, 1715\u20131727.e7 (2021).","journal-title":"Immunity"},{"key":"470_CR22","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1097\/TP.0b013e31818bc024","volume":"86","author":"C Benden","year":"2008","unstructured":"Benden, C. et al. Extracorporeal photopheresis after lung transplantation: a 10-year single-center experience. Transplantation 86, 1625\u20131627 (2008).","journal-title":"Transplantation"},{"key":"470_CR23","unstructured":"Urbani, L. et al. in Transplantation Proceedings 1175\u20131178 (Elsevier, 2004)."},{"key":"470_CR24","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1002\/art.23986","volume":"58","author":"Y He","year":"2008","unstructured":"He, Y. et al. Antiinflammatory effect of Rho kinase blockade via inhibition of NF-\u03baB activation in rheumatoid arthritis. Arthritis Rheum. 58, 3366\u20133376 (2008).","journal-title":"Arthritis Rheum."},{"key":"470_CR25","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s40472-017-0167-4","volume":"4","author":"A Dangi","year":"2017","unstructured":"Dangi, A. & Luo, X. Harnessing apoptotic cells for transplantation tolerance: current status and future perspectives. Curr. Transplant. Rep. 4, 270\u2013279 (2017).","journal-title":"Curr. Transplant. Rep."},{"key":"470_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-24825-y","volume":"12","author":"Y-H Chiu","year":"2021","unstructured":"Chiu, Y.-H. et al. Deacetylation as a receptor-regulated direct activation switch for pannexin channels. Nat. Commun. 12, 1\u201314 (2021).","journal-title":"Nat. Commun."},{"key":"470_CR27","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202152564","volume":"22","author":"SM Kelley","year":"2021","unstructured":"Kelley, S. M. & Ravichandran, K. S. Putting the brakes on phagocytosis: \u201cdon\u2019t-eat-me\u201d signaling in physiology and disease. EMBO Rep. 22, e52564 (2021).","journal-title":"EMBO Rep."},{"key":"470_CR28","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.4049\/jimmunol.148.7.2207","volume":"148","author":"VA Fadok","year":"1992","unstructured":"Fadok, V. A. et al. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148, 2207\u20132216 (1992). This classic study identifies PS as a signal exposed on apoptotic cells and its recognition by macrophages as an \u2018eat-me\u2019 signal.","journal-title":"J. Immunol."},{"key":"470_CR29","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3324\/haematol.2016.142273","volume":"101","author":"N Arashiki","year":"2016","unstructured":"Arashiki, N. et al. ATP11C is a major flippase in human erythrocytes and its defect causes congenital hemolytic anemia. Haematologica 101, 559\u2013565 (2016).","journal-title":"Haematologica"},{"key":"470_CR30","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.tcb.2015.08.003","volume":"25","author":"K Segawa","year":"2015","unstructured":"Segawa, K. & Nagata, S. An apoptotic \u2018eat me\u2019 signal: phosphatidylserine exposure. Trends Cell Biol. 25, 639\u2013650 (2015). This review details the key control mechanisms involved in asymmetric PS distribution in living cells versus its disruption in apoptotic cells.","journal-title":"Trends Cell Biol."},{"key":"470_CR31","doi-asserted-by":"publisher","first-page":"30257","DOI":"10.1074\/jbc.M114.583419","volume":"289","author":"J Suzuki","year":"2014","unstructured":"Suzuki, J., Imanishi, E. & Nagata, S. Exposure of phosphatidylserine by Xk-related protein family members during apoptosis. J. Biol. Chem. 289, 30257\u201330267 (2014).","journal-title":"J. Biol. Chem."},{"key":"470_CR32","doi-asserted-by":"publisher","first-page":"13305","DOI":"10.1074\/jbc.M113.457937","volume":"288","author":"J Suzuki","year":"2013","unstructured":"Suzuki, J. et al. Calcium-dependent phospholipid scramblase activity of TMEM16 protein family members. J. Biol. Chem. 288, 13305\u201313316 (2013).","journal-title":"J. Biol. Chem."},{"key":"470_CR33","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1126\/science.1236758","volume":"341","author":"J Suzuki","year":"2013","unstructured":"Suzuki, J., Denning, D. P., Imanishi, E., Horvitz, H. R. & Nagata, S. Xk-related protein 8 and CED-8 promote phosphatidylserine exposure in apoptotic cells. Science 341, 403\u2013406 (2013).","journal-title":"Science"},{"key":"470_CR34","doi-asserted-by":"publisher","first-page":"12800","DOI":"10.1073\/pnas.1516594112","volume":"112","author":"T Fujii","year":"2015","unstructured":"Fujii, T., Sakata, A., Nishimura, S., Eto, K. & Nagata, S. TMEM16F is required for phosphatidylserine exposure and microparticle release in activated mouse platelets. Proc. Natl Acad. Sci. USA 112, 12800\u201312805 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"470_CR35","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/nature06329","volume":"450","author":"D Park","year":"2007","unstructured":"Park, D. et al. BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO\/Dock180\/Rac module. Nature 450, 430\u2013434 (2007).","journal-title":"Nature"},{"key":"470_CR36","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.cub.2009.01.042","volume":"19","author":"D Park","year":"2009","unstructured":"Park, D., Hochreiter-Hufford, A. & Ravichandran, K. S. The phosphatidylserine receptor TIM-4 does not mediate direct signaling. Curr. Biol. 19, 346\u2013351 (2009).","journal-title":"Curr. Biol."},{"key":"470_CR37","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.immuni.2016.02.005","volume":"44","author":"CS Lee","year":"2016","unstructured":"Lee, C. S. et al. Boosting apoptotic cell clearance by colonic epithelial cells attenuates inflammation in vivo. Immunity 44, 807\u2013820 (2016).","journal-title":"Immunity"},{"key":"470_CR38","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.immuni.2007.11.011","volume":"27","author":"N Kobayashi","year":"2007","unstructured":"Kobayashi, N. et al. TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity 27, 927\u2013940 (2007).","journal-title":"Immunity"},{"key":"470_CR39","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.3390\/cells9071625","volume":"9","author":"B Moon","year":"2020","unstructured":"Moon, B. et al. Mertk interacts with Tim-4 to enhance Tim-4-mediated efferocytosis. Cells 9, 1625 (2020).","journal-title":"Cells"},{"key":"470_CR40","doi-asserted-by":"publisher","first-page":"7221","DOI":"10.1074\/jbc.RA118.006628","volume":"294","author":"C Nishi","year":"2019","unstructured":"Nishi, C., Yanagihashi, Y., Segawa, K. & Nagata, S. MERTK tyrosine kinase receptor together with TIM4 phosphatidylserine receptor mediates distinct signal transduction pathways for efferocytosis and cell proliferation. J. Biol. Chem. 294, 7221\u20137230 (2019).","journal-title":"J. Biol. Chem."},{"key":"470_CR41","doi-asserted-by":"publisher","first-page":"jcs222984","DOI":"10.1242\/jcs.222984","volume":"132","author":"BL Heckmann","year":"2019","unstructured":"Heckmann, B. L. & Green, D. R. LC3-associated phagocytosis at a glance. J. Cell Sci. 132, jcs222984 (2019).","journal-title":"J. Cell Sci."},{"key":"470_CR42","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nri2303","volume":"8","author":"G Lemke","year":"2008","unstructured":"Lemke, G. & Rothlin, C. V. Immunobiology of the TAM receptors. Nat. Rev. Immunol. 8, 327\u2013336 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"470_CR43","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1074\/jbc.M706906200","volume":"283","author":"N Tibrewal","year":"2008","unstructured":"Tibrewal, N. et al. Autophosphorylation docking site Tyr-867 in Mer receptor tyrosine kinase allows for dissociation of multiple signaling pathways for phagocytosis of apoptotic cells and down-modulation of lipopolysaccharide-inducible NF-\u03baB transcriptional activation. J. Biol. Chem. 283, 3618\u20133627 (2008).","journal-title":"J. Biol. Chem."},{"key":"470_CR44","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1182\/blood-2006-04-017368","volume":"109","author":"P Sen","year":"2007","unstructured":"Sen, P. et al. Apoptotic cells induce Mer tyrosine kinase-dependent blockade of NF-\u03baB activation in dendritic cells. Blood 109, 653\u2013660 (2007).","journal-title":"Blood"},{"key":"470_CR45","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.cell.2007.10.034","volume":"131","author":"CV Rothlin","year":"2007","unstructured":"Rothlin, C. V., Ghosh, S., Zuniga, E. I., Oldstone, M. B. & Lemke, G. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 131, 1124\u20131136 (2007). This seminal paper identifies Tyro3, Axl and MerTK family members as relevant in anti-inflammatory signalling.","journal-title":"Cell"},{"key":"470_CR46","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1084\/jem.20062293","volume":"205","author":"MA Wallet","year":"2008","unstructured":"Wallet, M. A. et al. MerTK is required for apoptotic cell-induced T cell tolerance. J. Exp. Med. 205, 219\u2013232 (2008).","journal-title":"J. Exp. Med."},{"key":"470_CR47","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.4049\/jimmunol.1000017","volume":"185","author":"AA Filardy","year":"2010","unstructured":"Filardy, A. A. et al. Proinflammatory clearance of apoptotic neutrophils induces an IL-12lowIL-10high regulatory phenotype in macrophages. J. Immunol. 185, 2044\u20132050 (2010).","journal-title":"J. Immunol."},{"key":"470_CR48","doi-asserted-by":"publisher","first-page":"3508","DOI":"10.4049\/jimmunol.1200662","volume":"189","author":"G Zizzo","year":"2012","unstructured":"Zizzo, G., Hilliard, B. A., Monestier, M. & Cohen, P. L. Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction. J. Immunol. 189, 3508\u20133520 (2012).","journal-title":"J. Immunol."},{"key":"470_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms10871","volume":"7","author":"S-Y Park","year":"2016","unstructured":"Park, S.-Y. et al. Stabilin-2 modulates the efficiency of myoblast fusion during myogenic differentiation and muscle regeneration. Nat. Commun. 7, 1\u201315 (2016).","journal-title":"Nat. Commun."},{"key":"470_CR50","doi-asserted-by":"publisher","first-page":"5275","DOI":"10.1158\/1078-0432.CCR-12-1451","volume":"19","author":"CT Cummings","year":"2013","unstructured":"Cummings, C. T., DeRyckere, D., Earp, H. S. & Graham, D. K. Molecular pathways: MERTK signaling in cancer. Clin. Cancer Res. 19, 5275\u20135280 (2013).","journal-title":"Clin. Cancer Res."},{"key":"470_CR51","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s12272-019-01167-4","volume":"42","author":"M Park","year":"2019","unstructured":"Park, M. & Kang, K. W. Phosphatidylserine receptor-targeting therapies for the treatment of cancer. Arch. Pharmacal Res. 42, 617\u2013628 (2019).","journal-title":"Arch. Pharmacal Res."},{"key":"470_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15191-1","volume":"7","author":"KK Penberthy","year":"2017","unstructured":"Penberthy, K. K. et al. Context-dependent compensation among phosphatidylserine-recognition receptors. Sci. Rep. 7, 14623 (2017).","journal-title":"Sci. Rep."},{"key":"470_CR53","doi-asserted-by":"publisher","first-page":"19246","DOI":"10.1073\/pnas.1114799108","volume":"108","author":"K Segawa","year":"2011","unstructured":"Segawa, K., Suzuki, J. & Nagata, S. Constitutive exposure of phosphatidylserine on viable cells. Proc. Natl Acad. Sci. USA 108, 19246\u201319251 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"470_CR54","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1083\/jcb.200708043","volume":"180","author":"RK Tsai","year":"2008","unstructured":"Tsai, R. K. & Discher, D. E. Inhibition of \u201cself\u201d engulfment through deactivation of myosin-II at the phagocytic synapse between human cells. J. Cell Biol. 180, 989\u20131003 (2008).","journal-title":"J. Cell Biol."},{"key":"470_CR55","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41586-019-1456-0","volume":"572","author":"AA Barkal","year":"2019","unstructured":"Barkal, A. A. et al. CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy. Nature 572, 392\u2013396 (2019). Together with Brown et al. (2002), this pioneering study highlights the importance of \u2018do not eat-me\u2019 signals CD31 and CD24 in immunotherapies.","journal-title":"Nature"},{"key":"470_CR56","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/nature00811","volume":"418","author":"S Brown","year":"2002","unstructured":"Brown, S. et al. Apoptosis disables CD31-mediated cell detachment from phagocytes promoting binding and engulfment. Nature 418, 200\u2013203 (2002).","journal-title":"Nature"},{"key":"470_CR57","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1172\/JCI80300","volume":"125","author":"AM Fond","year":"2015","unstructured":"Fond, A. M., Lee, C. S., Schulman, I. G., Kiss, R. S. & Ravichandran, K. S. Apoptotic cells trigger a membrane-initiated pathway to increase ABCA1. J. Clin. Invest. 125, 2748\u20132758 (2015).","journal-title":"J. Clin. Invest."},{"key":"470_CR58","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1161\/CIRCRESAHA.117.312333","volume":"122","author":"M Viaud","year":"2018","unstructured":"Viaud, M. et al. Lysosomal cholesterol hydrolysis couples efferocytosis to anti-inflammatory oxysterol production. Circ. Res. 122, 1369\u20131384 (2018).","journal-title":"Circ. Res."},{"key":"470_CR59","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.29292","volume":"6","author":"X Xian","year":"2017","unstructured":"Xian, X. et al. LRP1 integrates murine macrophage cholesterol homeostasis and inflammatory responses in atherosclerosis. eLife, 6, e29292 (2017).","journal-title":"eLife"},{"key":"470_CR60","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1189\/jlb.0307192","volume":"82","author":"D Cui","year":"2007","unstructured":"Cui, D. et al. Pivotal advance: macrophages become resistant to cholesterol-induced death after phagocytosis of apoptotic cells. J. Leukoc. Biol. 82, 1040\u20131050 (2007). This important study highlights the metabolic adaptability of macrophages, enabling them to handle the cholesterol burden derived from apoptotic cargo.","journal-title":"J. Leukoc. Biol."},{"key":"470_CR61","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nri2748","volume":"10","author":"CK Glass","year":"2010","unstructured":"Glass, C. K & Saijo, K. Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells. Nat. Rev. Imuunol. 10, 365\u2013376 (2010).","journal-title":"Nat. Rev. Imuunol."},{"key":"470_CR62","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.immuni.2009.06.018","volume":"31","author":"NA- Gonzalez","year":"2009","unstructured":"Gonzalez, N. A-. et al. Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity 31, 245\u2013258 (2009).","journal-title":"Immunity"},{"key":"470_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2019.06.223","volume":"287","author":"S Ivanov","year":"2019","unstructured":"Ivanov, S. et al. Lysosomal cholesterol hydrolysis couples efferocytosis to anti-inflammatory oxysterol production. Atherosclerosis 287, e77 (2019).","journal-title":"Atherosclerosis"},{"key":"470_CR64","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.cmet.2020.01.001","volume":"31","author":"A Yurdagul Jr","year":"2020","unstructured":"Yurdagul, A. Jr et al. Macrophage metabolism of apoptotic cell-derived arginine promotes continual efferocytosis and resolution of injury. Cell Metab. 31, 518\u2013533.e10 (2020). This work presents an important finding highlighting the utilization of apoptotic cargo-derived metabolites by macrophages during efferocytosis.","journal-title":"Cell Metab."},{"key":"470_CR65","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1016\/j.cmet.2021.10.015","volume":"33","author":"BD Gerlach","year":"2021","unstructured":"Gerlach, B. D. et al. Efferocytosis induces macrophage proliferation to help resolve tissue injury. Cell Metab. 33, 2445\u20132463.e8 (2021).","journal-title":"Cell Metab."},{"key":"470_CR66","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/s41586-018-0735-5","volume":"563","author":"S Morioka","year":"2018","unstructured":"Morioka, S. et al. Efferocytosis induces a novel SLC program to promote glucose uptake and lactate release. Nature 563, 714\u2013718 (2018). This work identifies a role for the SLC family of proteins during efferocytosis, and how SLC gene induction can link to improved phagocytosis and anti-inflammatory responses.","journal-title":"Nature"},{"key":"470_CR67","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.cmet.2018.12.004","volume":"29","author":"S Zhang","year":"2019","unstructured":"Zhang, S. et al. Efferocytosis fuels requirements of fatty acid oxidation and the electron transport chain to polarize macrophages for tissue repair. Cell Met. 29, 443\u2013456 (2019).","journal-title":"Cell Met."},{"key":"470_CR68","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.cell.2017.08.041","volume":"171","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. Mitochondrial fission promotes the continued clearance of apoptotic cells by macrophages. Cell 171, 331\u2013345.e22 (2017).","journal-title":"Cell"},{"key":"470_CR69","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.jaci.2015.07.034","volume":"136","author":"RF Fernandez-Boyanapalli","year":"2015","unstructured":"Fernandez-Boyanapalli, R. F. et al. Impaired efferocytosis in human chronic granulomatous disease is reversed by pioglitazone treatment. J. Allergy Clin. Immunol. 136, 1399 (2015).","journal-title":"J. Allergy Clin. Immunol."},{"key":"470_CR70","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/gtc.12456","volume":"22","author":"K Tanegashima","year":"2017","unstructured":"Tanegashima, K. et al. Epigenetic regulation of the glucose transporter gene Slc2a1 by \u03b2-hydroxybutyrate underlies preferential glucose supply to the brain of fasted mice. Genes. Cell 22, 71\u201383 (2017).","journal-title":"Genes. Cell"},{"key":"470_CR71","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nrd4626","volume":"14","author":"L Lin","year":"2015","unstructured":"Lin, L., Yee, S. W., Kim, R. B. & Giacomini, K. M. SLC transporters as therapeutic targets: emerging opportunities. Nat. Rev. Drug Discov. 14, 543\u2013560 (2015).","journal-title":"Nat. Rev. Drug Discov."},{"key":"470_CR72","doi-asserted-by":"publisher","first-page":"35896","DOI":"10.1074\/jbc.M506210200","volume":"280","author":"Y Wang","year":"2005","unstructured":"Wang, Y. & Oram, J. F. Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a phospholipase D2 pathway. J. Biol. Chem. 280, 35896\u201335903 (2005).","journal-title":"J. Biol. Chem."},{"key":"470_CR73","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1194\/jlr.M600437-JLR200","volume":"48","author":"Y Wang","year":"2007","unstructured":"Wang, Y. & Oram, J. F. Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a protein kinase C\u03b4 pathway. J. Lipid Res. 48, 1062\u20131068 (2007).","journal-title":"J. Lipid Res."},{"key":"470_CR74","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.bbalip.2009.03.011","volume":"1791","author":"C Tang","year":"2009","unstructured":"Tang, C. & Oram, J. F. The cell cholesterol exporter ABCA1 as a protector from cardiovascular disease and diabetes. Biochim. Biophys. Acta 1791, 563\u2013572 (2009).","journal-title":"Biochim. Biophys. Acta"},{"key":"470_CR75","doi-asserted-by":"publisher","first-page":"6526","DOI":"10.1073\/pnas.1524292113","volume":"113","author":"B Cai","year":"2016","unstructured":"Cai, B. et al. MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation. Proc. Natl Acad. Sci. USA 113, 6526\u20136531 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"470_CR76","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/cvr\/cvs301","volume":"97","author":"U Garbin","year":"2013","unstructured":"Garbin, U. et al. Expansion of necrotic core and shedding of Mertk receptor in human carotid plaques: a role for oxidized polyunsaturated fatty acids? Cardiovasc. Res. 97, 125\u2013133 (2013).","journal-title":"Cardiovasc. Res."},{"key":"470_CR77","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1172\/JCI90520","volume":"127","author":"B Cai","year":"2017","unstructured":"Cai, B. et al. MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis. J. Clin. Invest. 127, 564\u2013568 (2017).","journal-title":"J. Clin. Invest."},{"key":"470_CR78","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1172\/JCI94735","volume":"127","author":"AC Doran","year":"2017","unstructured":"Doran, A. C. et al. CAMKII\u03b3 suppresses an efferocytosis pathway in macrophages and promotes atherosclerotic plaque necrosis. J. Clin. Invest. 127, 4075\u20134089 (2017).","journal-title":"J. Clin. Invest."},{"key":"470_CR79","doi-asserted-by":"publisher","first-page":"eaar3721","DOI":"10.1126\/scisignal.aar3721","volume":"11","author":"B Cai","year":"2018","unstructured":"Cai, B. et al. MerTK signaling in macrophages promotes the synthesis of inflammation resolution mediators by suppressing CaMKII activity. Sci. Signal. 11, eaar3721 (2018).","journal-title":"Sci. Signal."},{"key":"470_CR80","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.4049\/jimmunol.164.4.1663","volume":"164","author":"C Godson","year":"2000","unstructured":"Godson, C. et al. Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J. Immunol. 164, 1663\u20131667 (2000).","journal-title":"J. Immunol."},{"key":"470_CR81","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.3389\/fimmu.2017.01400","volume":"8","author":"J Dalli","year":"2017","unstructured":"Dalli, J. & Serhan, C. N. Pro-resolving mediators in regulating and conferring macrophage function. Front. Immunol. 8, 1400 (2017).","journal-title":"Front. Immunol."},{"key":"470_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12859","volume":"7","author":"G Fredman","year":"2016","unstructured":"Fredman, G. et al. An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques. Nat. Commun. 7, 12859 (2016).","journal-title":"Nat. Commun."},{"key":"470_CR83","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.phrs.2019.03.012","volume":"144","author":"CM Manega","year":"2019","unstructured":"Manega, C. M. et al. 12(S)-Hydroxyeicosatetraenoic acid downregulates monocyte-derived macrophage efferocytosis: new insights in atherosclerosis. Pharmacol. Res. 144, 336\u2013342 (2019).","journal-title":"Pharmacol. Res."},{"key":"470_CR84","doi-asserted-by":"publisher","first-page":"581","DOI":"10.4049\/jimmunol.182.1.581","volume":"182","author":"H Komura","year":"2009","unstructured":"Komura, H., Miksa, M., Wu, R., Goyert, S. M. & Wang, P. Milk fat globule epidermal growth factor\u2013factor VIII is down-regulated in sepsis via the lipopolysaccharide\u2013CD14 pathway. J. Immunol. 182, 581\u2013587 (2009).","journal-title":"J. Immunol."},{"key":"470_CR85","doi-asserted-by":"publisher","first-page":"49911","DOI":"10.1074\/jbc.M306079200","volume":"278","author":"A-C Tosello-Trampont","year":"2003","unstructured":"Tosello-Trampont, A.-C., Nakada-Tsukui, K. & Ravichandran, K. S. Engulfment of apoptotic cells is negatively regulated by Rho-mediated signaling. J. Biol. Chem. 278, 49911\u201349919 (2003).","journal-title":"J. Biol. Chem."},{"key":"470_CR86","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.atherosclerosis.2009.04.025","volume":"207","author":"D-J Wu","year":"2009","unstructured":"Wu, D.-J. et al. Effects of fasudil on early atherosclerotic plaque formation and established lesion progression in apolipoprotein E-knockout mice. Atherosclerosis 207, 68\u201373 (2009).","journal-title":"Atherosclerosis"},{"key":"470_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2016.08.043","volume":"84","author":"T Toyama","year":"2016","unstructured":"Toyama, T. et al. Fasudil ameliorates fibrosis, vasculopathy, and immune abnormalities in animal models of systemic sclerosis. J. Dermatol. Sci. 84, e11 (2016).","journal-title":"J. Dermatol. Sci."},{"key":"470_CR88","first-page":"BR112","volume":"16","author":"Y Li","year":"2010","unstructured":"Li, Y., Wu, Y., Wang, Z., Zhang, X.-H. & Wu, W.-K. Fasudil attenuates lipopolysaccharide-induced acute lung injury in mice through the Rho\/Rho kinase pathway. Med. Sci. Monit. 16, BR112\u2013BR118 (2010).","journal-title":"Med. Sci. Monit."},{"key":"470_CR89","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/S0016-5085(03)00283-X","volume":"124","author":"J-P Segain","year":"2003","unstructured":"Segain, J.-P. et al. Rho kinase blockade prevents inflammation via nuclear factor \u03baB inhibition: evidence in Crohn\u2019s disease and experimental colitis. Gastroenterology 124, 1180\u20131187 (2003).","journal-title":"Gastroenterology"},{"key":"470_CR90","doi-asserted-by":"publisher","first-page":"964","DOI":"10.3390\/cells8090964","volume":"8","author":"I Galv\u00e3o","year":"2019","unstructured":"Galv\u00e3o, I. et al. ROCK inhibition drives resolution of acute inflammation by enhancing neutrophil apoptosis. Cells 8, 964 (2019).","journal-title":"Cells"},{"key":"470_CR91","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/nature18935","volume":"536","author":"Y Kojima","year":"2016","unstructured":"Kojima, Y. et al. CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis. Nature 536, 86\u201390 (2016). This study highlights how administration of CD47 blocking antibodies could effectively enhance efferocytosis, and aid in suppression of atherosclerosis in mouse models.","journal-title":"Nature"},{"key":"470_CR92","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvab369","author":"B Singla","year":"2021","unstructured":"Singla, B. et al. Loss of myeloid cell-specific SIRP\u03b1, but not CD47, attenuates inflammation and suppresses atherosclerosis. Cardiovasc. Res. https:\/\/doi.org\/10.1093\/cvr\/cvab369 (2021).","journal-title":"Cardiovasc. Res."},{"key":"470_CR93","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41565-019-0619-3","volume":"15","author":"AM Flores","year":"2020","unstructured":"Flores, A. M. et al. Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis. Nat. Nanotechnol. 15, 154\u2013161 (2020). This work presents a landmark technological development in nanoparticle-based targeting of efferocytosis for improving prognosis in atherosclerosis.","journal-title":"Nat. Nanotechnol."},{"key":"470_CR94","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41418-019-0370-1","volume":"27","author":"BD Gerlach","year":"2020","unstructured":"Gerlach, B. D. et al. Resolvin D1 promotes the targeting and clearance of necroptotic cells. Cell Death Differ. 27, 525\u2013539 (2020).","journal-title":"Cell Death Differ."},{"key":"470_CR95","doi-asserted-by":"publisher","first-page":"7604","DOI":"10.1073\/pnas.112059299","volume":"99","author":"SB Joseph","year":"2002","unstructured":"Joseph, S. B. et al. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc. Natl Acad. Sci. USA 99, 7604\u20137609 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"470_CR96","first-page":"819","volume":"5","author":"E Vucic","year":"2012","unstructured":"Vucic, E. et al. Regression of inflammation in atherosclerosis by the LXR agonist R211945: a noninvasive assessment and comparison with atorvastatin. JACC 5, 819\u2013828 (2012).","journal-title":"JACC"},{"key":"470_CR97","doi-asserted-by":"publisher","first-page":"107823","DOI":"10.1016\/j.intimp.2021.107823","volume":"97","author":"M Arabpour","year":"2021","unstructured":"Arabpour, M., Saghazadeh, A. & Rezaei, N. Anti-inflammatory and M2 macrophage polarization-promoting effect of mesenchymal stem cell-derived exosomes. Int. Immunopharmacol. 97, 107823 (2021).","journal-title":"Int. Immunopharmacol."},{"key":"470_CR98","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12712","volume":"53","author":"W Jiang","year":"2020","unstructured":"Jiang, W. & Xu, J. Immune modulation by mesenchymal stem cells. Cell Prolif. 53, e12712 (2020).","journal-title":"Cell Prolif."},{"key":"470_CR99","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014397","volume":"9","author":"Z Zhang","year":"2020","unstructured":"Zhang, Z. et al. Mesenchymal stem cells promote the resolution of cardiac inflammation after ischemia reperfusion via enhancing efferocytosis of neutrophils. J. Am. Heart Assoc. 9, e014397 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"470_CR100","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.cell.2014.10.039","volume":"159","author":"BK Kennedy","year":"2014","unstructured":"Kennedy, B. K. et al. Geroscience: linking aging to chronic disease. Cell 159, 709\u2013713 (2014).","journal-title":"Cell"},{"key":"470_CR101","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1002\/eji.201343921","volume":"44","author":"M Pinti","year":"2014","unstructured":"Pinti, M. et al. Circulating mitochondrial DNA increases with age and is a familiar trait: implications for \u201cinflamm-aging\u201d. Eur. J. Immunol. 44, 1552\u20131562 (2014).","journal-title":"Eur. J. Immunol."},{"key":"470_CR102","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/j.1365-2249.2008.03658.x","volume":"152","author":"T Aprahamian","year":"2008","unstructured":"Aprahamian, T., Takemura, Y., Goukassian, D. & Walsh, K. Ageing is associated with diminished apoptotic cell clearance in vivo. Clin. Exp. Immunol. 152, 448\u2013455 (2008).","journal-title":"Clin. Exp. Immunol."},{"key":"470_CR103","doi-asserted-by":"publisher","first-page":"4235","DOI":"10.4049\/jimmunol.1401313","volume":"193","author":"HH Arnardottir","year":"2014","unstructured":"Arnardottir, H. H., Dalli, J., Colas, R. A., Shinohara, M. & Serhan, C. N. Aging delays resolution of acute inflammation in mice: reprogramming the host response with novel nano-proresolving medicines. J. Immunol. 193, 4235\u20134244 (2014).","journal-title":"J. Immunol."},{"key":"470_CR104","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.molmet.2019.10.008","volume":"31","author":"B Tourki","year":"2020","unstructured":"Tourki, B. et al. Lack of resolution sensor drives age-related cardiometabolic and cardiorenal defects and impedes inflammation-resolution in heart failure. Mol. Metab. 31, 138\u2013149 (2020).","journal-title":"Mol. Metab."},{"key":"470_CR105","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41590-020-0646-0","volume":"21","author":"RP De Maeyer","year":"2020","unstructured":"De Maeyer, R. P. et al. Blocking elevated p38 MAPK restores efferocytosis and inflammatory resolution in the elderly. Nat. Immunol. 21, 615\u2013625 (2020). This important study details the direct implications of poor efferocytosis in inflammation resolution in aged humans, and identifies p38MAPK and TIM4 as targets for improving efferocytosis.","journal-title":"Nat. Immunol."},{"key":"470_CR106","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nrc2440","volume":"8","author":"FdA di Fagagna","year":"2008","unstructured":"di Fagagna, Fd. A. Living on a break: cellular senescence as a DNA-damage response. Nat. Rev. Cancer 8, 512\u2013522 (2008).","journal-title":"Nat. Rev. Cancer"},{"key":"470_CR107","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/35036093","volume":"1","author":"JW Shay","year":"2000","unstructured":"Shay, J. W. & Wright, W. E. Hayflick, his limit, and cellular ageing. Nat. Rev. Mol. Cell Biol. 1, 72\u201376 (2000).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"470_CR108","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.cmet.2015.11.011","volume":"23","author":"CD Wiley","year":"2016","unstructured":"Wiley, C. D. et al. Mitochondrial dysfunction induces senescence with a distinct secretory phenotype. Cell Metab. 23, 303\u2013314 (2016).","journal-title":"Cell Metab."},{"key":"470_CR109","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/nrd.2017.116","volume":"16","author":"BG Childs","year":"2017","unstructured":"Childs, B. G. et al. Senescent cells: an emerging target for diseases of ageing. Nat. Rev. Drug Discov. 16, 718 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"470_CR110","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.cell.2005.02.003","volume":"120","author":"J Campisi","year":"2005","unstructured":"Campisi, J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120, 513\u2013522 (2005).","journal-title":"Cell"},{"key":"470_CR111","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.18632\/aging.100991","volume":"8","author":"BM Hall","year":"2016","unstructured":"Hall, B. M. et al. Aging of mice is associated with p16(Ink4a)-and \u03b2-galactosidase-positive macrophage accumulation that can be induced in young mice by senescent cells. Aging 8, 1294 (2016).","journal-title":"Aging"},{"key":"470_CR112","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1083\/jcb.201009094","volume":"192","author":"F Rodier","year":"2011","unstructured":"Rodier, F. & Campisi, J. Four faces of cellular senescence. J. Cell Biol. 192, 547\u2013556 (2011).","journal-title":"J. Cell Biol."},{"key":"470_CR113","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1096\/fj.201902126R","volume":"34","author":"N Rymut","year":"2020","unstructured":"Rymut, N. et al. Resolvin D1 promotes efferocytosis in aging by limiting senescent cell-induced MerTK cleavage. FASEB J. 34, 597\u2013609 (2020).","journal-title":"FASEB J."},{"key":"470_CR114","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature10600","volume":"479","author":"DJ Baker","year":"2011","unstructured":"Baker, D. J. et al. Clearance of p16 Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479, 232\u2013236 (2011).","journal-title":"Nature"},{"key":"470_CR115","first-page":"479","volume":"41","author":"JA Martin","year":"2004","unstructured":"Martin, J. A., Brown, T., Heiner, A. & Buckwalter, J. A. Post-traumatic osteoarthritis: the role of accelerated chondrocyte senescence. Biorheology 41, 479\u2013491 (2004).","journal-title":"Biorheology"},{"key":"470_CR116","first-page":"4235","volume":"193","author":"J Dalli","year":"2014","unstructured":"Dalli, J., Colas, R., Shinohara, M. & Serhan, C. N. Aging delays resolution of acute inflammation in mice: reprogramming the host response with novel nano-proresolving. Medicines 193, 4235\u20134244 (2014).","journal-title":"Medicines"},{"key":"470_CR117","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57\u201370 (2000).","journal-title":"Cell"},{"key":"470_CR118","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"470_CR119","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nrc1256","volume":"4","author":"JW Pollard","year":"2004","unstructured":"Pollard, J. W. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 4, 71\u201378 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"470_CR120","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/nrc2444","volume":"8","author":"C Murdoch","year":"2008","unstructured":"Murdoch, C., Muthana, M., Coffelt, S. B. & Lewis, C. E. The role of myeloid cells in the promotion of tumour angiogenesis. Nat. Rev. Cancer 8, 618\u2013631 (2008).","journal-title":"Nat. Rev. Cancer"},{"key":"470_CR121","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.ejca.2006.01.003","volume":"42","author":"A Sica","year":"2006","unstructured":"Sica, A., Schioppa, T., Mantovani, A. & Allavena, P. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur. J. Cancer 42, 717\u2013727 (2006).","journal-title":"Eur. J. Cancer"},{"key":"470_CR122","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/bjc.2015.323","volume":"113","author":"Q Zhang","year":"2015","unstructured":"Zhang, Q. et al. TIM-4 promotes the growth of non-small-cell lung cancer in a RGD motif-dependent manner. Br. J. Cancer 113, 1484\u20131492 (2015).","journal-title":"Br. J. Cancer"},{"key":"470_CR123","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.canlet.2018.08.012","volume":"436","author":"X Tan","year":"2018","unstructured":"Tan, X., Zhang, Z., Yao, H. & Shen, L. Tim-4 promotes the growth of colorectal cancer by activating angiogenesis and recruiting tumor-associated macrophages via the PI3K\/AKT\/mTOR signaling pathway. Cancer Lett. 436, 119\u2013128 (2018).","journal-title":"Cancer Lett."},{"key":"470_CR124","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.tips.2018.10.008","volume":"40","author":"R Tesi","year":"2019","unstructured":"Tesi, R. MDSC; the most important cell you have never heard of. Trends Pharmacol. Sci. 40, 4\u20137 (2019).","journal-title":"Trends Pharmacol. Sci."},{"key":"470_CR125","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1158\/2326-6066.CIR-19-0008","volume":"7","author":"A Holtzhausen","year":"2019","unstructured":"Holtzhausen, A. et al. TAM family receptor kinase inhibition reverses MDSC-mediated suppression and augments anti-PD-1 therapy in melanoma. Cancer Immunol. Res. 7, 1672 (2019).","journal-title":"Cancer Immunol. Res."},{"key":"470_CR126","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1172\/JCI67655","volume":"123","author":"RS Cook","year":"2013","unstructured":"Cook, R. S. et al. MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis. J. Clin. Invest. 123, 3231\u20133242 (2013). This study highlights the role of MerTK signalling in poor cancer prognosis and the advantages of using inhibitors of PS receptors as therapeutics.","journal-title":"J. Clin. Invest."},{"key":"470_CR127","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nrc3847","volume":"14","author":"DK Graham","year":"2014","unstructured":"Graham, D. K., DeRyckere, D., Davies, K. D. & Earp, H. S. The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer. Nat. Rev. Cancer 14, 769\u2013785 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"470_CR128","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/imr.12587","volume":"280","author":"S Kumar","year":"2017","unstructured":"Kumar, S., Calianese, D. & Birge, R. B. Efferocytosis of dying cells differentially modulate immunological outcomes in tumor microenvironment. Immunol. Rev. 280, 149\u2013164 (2017).","journal-title":"Immunol. Rev."},{"key":"470_CR129","volume":"2","author":"DB Vaught","year":"2015","unstructured":"Vaught, D. B., Stanford, J. C. & Cook, R. S. Efferocytosis creates a tumor microenvironment supportive of tumor survival and metastasis. Cancer Cell Microenviron. 2, e666 (2015).","journal-title":"Cancer Cell Microenviron."},{"key":"470_CR130","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1158\/0008-5472.CAN-09-2997","volume":"70","author":"SJ Holland","year":"2010","unstructured":"Holland, S. J. et al. R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer. Cancer Res. 70, 1544\u20131554 (2010).","journal-title":"Cancer Res."},{"key":"470_CR131","doi-asserted-by":"publisher","first-page":"5878","DOI":"10.1158\/0008-5472.CAN-14-1009","volume":"74","author":"C Wilson","year":"2014","unstructured":"Wilson, C. et al. AXL inhibition sensitizes mesenchymal cancer cells to antimitotic drugs. Cancer Res. 74, 5878\u20135890 (2014).","journal-title":"Cancer Res."},{"key":"470_CR132","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.278369","author":"SM Post","year":"2020","unstructured":"Post, S. M. et al. AXL\/MERTK inhibitor ONO-7475 potently synergizes with venetoclax and overcomes venetoclax resistance to kill FLT3-ITD acute myeloid leukemia. Haematologica https:\/\/doi.org\/10.3324\/haematol.2021.278369 (2020).","journal-title":"Haematologica"},{"key":"470_CR133","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.85630","volume":"1","author":"KA Minson","year":"2016","unstructured":"Minson, K. A. et al. The MERTK\/FLT3 inhibitor MRX-2843 overcomes resistance-conferring FLT3 mutations in acute myeloid leukemia. JCI Insight 1, e85630 (2016).","journal-title":"JCI Insight"},{"key":"470_CR134","doi-asserted-by":"publisher","unstructured":"Subbiah, V. et al. Trials in progress: A phase 1, open-label, dose-escalation, pharmacokinetic, safety and tolerability study of the selective TAM kinase inhibitor PF-07265807 in patients with advanced or metastatic solid tumors [abstract TPS2671]. J. Clin. Oncol. https:\/\/doi.org\/10.1200\/JCO.2021.39.15_suppl.TPS2671 (2021).","DOI":"10.1200\/JCO.2021.39.15_suppl.TPS2671"},{"key":"470_CR135","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1182\/blood-2020-134718","volume":"136","author":"AM Zeidan","year":"2020","unstructured":"Zeidan, A. M. et al. The STIMULUS Program: clinical trials evaluating sabatolimab (MBG453) combination therapy in patients (Pts) with higher-risk myelodysplastic syndromes (HR-MDS) or acute mMyeloid leukemia (AML). Blood 136, 45\u201346 (2020).","journal-title":"Blood"},{"key":"470_CR136","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1182\/blood-2021-146039","volume":"138","author":"AM Brunner","year":"2021","unstructured":"Brunner, A. M. et al. Efficacy and safety of sabatolimab (MBG453) in combination with hypomethylating agents (HMAs) in patients (Pts) with very high\/high-risk myelodysplastic syndrome (vHR\/HR-MDS) and acute myeloid leukemia (AML): final analysis from a phase Ib study. Blood 138, 244 (2021).","journal-title":"Blood"},{"key":"470_CR137","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1182\/blood-2020-136855","volume":"136","author":"AM Brunner","year":"2020","unstructured":"Brunner, A. M. et al. Efficacy and safety of sabatolimab (MBG453) in combination with hypomethylating agents (HMAs) in patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR-MDS): updated results from a phase 1b study. Blood 136, 1\u20132 (2020).","journal-title":"Blood"},{"key":"470_CR138","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1158\/1078-0432.CCR-20-4405","volume":"27","author":"JJ Harding","year":"2021","unstructured":"Harding, J. J. et al. Blocking TIM-3 in treatment-refractory advanced solid tumors: a phase Ia\/b study of LY3321367 with or without an anti-PD-L1 antibody. Clin. Cancer Res. 27, 2168\u20132178 (2021).","journal-title":"Clin. Cancer Res."},{"key":"470_CR139","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.cell.2009.05.045","volume":"138","author":"R Majeti","year":"2009","unstructured":"Majeti, R. et al. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell 138, 286\u2013299 (2009).","journal-title":"Cell"},{"key":"470_CR140","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2009.05.046","volume":"138","author":"S Jaiswal","year":"2009","unstructured":"Jaiswal, S. et al. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell 138, 271\u2013285 (2009).","journal-title":"Cell"},{"key":"470_CR141","doi-asserted-by":"publisher","first-page":"11103","DOI":"10.1073\/pnas.1305569110","volume":"110","author":"D Tseng","year":"2013","unstructured":"Tseng, D. et al. Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response. Proc. Natl Acad. Sci. USA 110, 11103\u201311108 (2013). Together with Jaiswal et al. (2009), this paper presents early findings highlighting the role of CD47 in driving a poor cancer prognosis.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"470_CR142","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.cell.2010.07.044","volume":"142","author":"MP Chao","year":"2010","unstructured":"Chao, M. P. et al. Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma. Cell 142, 699\u2013713 (2010).","journal-title":"Cell"},{"key":"470_CR143","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1126\/science.1238856","volume":"341","author":"K Weiskopf","year":"2013","unstructured":"Weiskopf, K. et al. Engineered SIRP\u03b1 variants as immunotherapeutic adjuvants to anticancer antibodies. Science 341, 88\u201391 (2013).","journal-title":"Science"},{"key":"470_CR144","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.it.2017.12.005","volume":"39","author":"A Veillette","year":"2018","unstructured":"Veillette, A. & Chen, J. SIRP\u03b1\u2013CD47 immune checkpoint blockade in anticancer therapy. Trends Immunol. 39, 173\u2013184 (2018).","journal-title":"Trends Immunol."},{"key":"470_CR145","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature22396","volume":"545","author":"SR Gordon","year":"2017","unstructured":"Gordon, S. R. et al. PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature 545, 495\u2013499 (2017). This study's findings bring forward the role played by PD1 expression and signalling in reducing phagocytosis and removal of tumour cells.","journal-title":"Nature"},{"key":"470_CR146","doi-asserted-by":"crossref","unstructured":"Burris III, H. A. et al. A first-in-human study of AO-176, a highly differentiated anti-CD47 antibody, in patients with advanced solid tumors [abstract 2516]. J. Clin. Oncol. 39, no. 15_suppl 2516\u20132516 (2021).","DOI":"10.1200\/JCO.2021.39.15_suppl.2516"},{"key":"470_CR147","doi-asserted-by":"crossref","unstructured":"Roohullah, A. et al. First-in-human phase 1 dose escalation study of HX009, a novel recombinant humanized anti-PD-1 and CD47 bispecific antibody, in patients with advanced malignancies [abstract 2517]. J. Clin. Oncol. 39, no. 15_suppl 2517\u20132517 (2021).","DOI":"10.1200\/JCO.2021.39.15_suppl.2517"},{"key":"470_CR148","doi-asserted-by":"crossref","unstructured":"Gan, H. K. et al. Safety of AK117, an anti-CD47 monoclonal antibody, in patients with advanced or metastatic solid tumors in a phase I study [abstract 2630]. J. Clin. Oncol. 39, no. 15_suppl 2630\u20132630 (2021).","DOI":"10.1200\/JCO.2021.39.15_suppl.2630"},{"key":"470_CR149","first-page":"1","volume":"1","author":"N Lakhani","year":"2018","unstructured":"Lakhani, N. et al. A phase 1 study of ALX148, a CD47 blocker, alone and in combination with established anti-cancer antibodies in patients with advanced malignancy and non Hodgkin lymphoma. Breast 1, 1 (2018).","journal-title":"Breast"},{"key":"470_CR150","doi-asserted-by":"publisher","first-page":"67","DOI":"10.36401\/JIPO-21-X2","volume":"4","author":"F Haddad","year":"2021","unstructured":"Haddad, F. & Daver, N. Targeting CD47\/SIRP\u03b1 in acute myeloid leukemia and myelodysplastic syndrome: preclinical and clinical developments of magrolimab. J. Immunother. Precis. Oncol. 4, 67\u201371 (2021).","journal-title":"J. Immunother. Precis. Oncol."},{"key":"470_CR151","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41590-017-0004-z","volume":"19","author":"AA Barkal","year":"2018","unstructured":"Barkal, A. A. et al. Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy. Nat. Immunol. 19, 76\u201384 (2018).","journal-title":"Nat. Immunol."},{"key":"470_CR152","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nri.2016.107","volume":"17","author":"L Galluzzi","year":"2017","unstructured":"Galluzzi, L., Buqu\u00e9, A., Kepp, O., Zitvogel, L. & Kroemer, G. Immunogenic cell death in cancer and infectious disease. Nat. Rev. Immunol. 17, 97 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"470_CR153","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","volume":"31","author":"G Kroemer","year":"2013","unstructured":"Kroemer, G., Galluzzi, L., Kepp, O. & Zitvogel, L. Immunogenic cell death in cancer therapy. Annu. Rev. Immunol. 31, 51\u201372 (2013).","journal-title":"Annu. Rev. Immunol."},{"key":"470_CR154","doi-asserted-by":"publisher","first-page":"4854","DOI":"10.1111\/jcmm.14356","volume":"23","author":"J Zhou","year":"2019","unstructured":"Zhou, J. et al. Immunogenic cell death in cancer therapy: present and emerging inducers. J. Cell. Mol. Med. 23, 4854\u20134865 (2019).","journal-title":"J. Cell. Mol. Med."},{"key":"470_CR155","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1038\/s41556-019-0431-1","volume":"21","author":"JSA Perry","year":"2019","unstructured":"Perry, J. S. A. et al. Interpreting an apoptotic corpse as anti-inflammatory involves a chloride sensing pathway. Nat. Cell Biol. 21, 1532\u20131543 (2019).","journal-title":"Nat. Cell Biol."},{"key":"470_CR156","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.coi.2019.05.007","volume":"60","author":"SM Behar","year":"2019","unstructured":"Behar, S. M. & Briken, V. Apoptosis inhibition by intracellular bacteria and its consequence on host immunity. Curr. Opin. Immunol. 60, 103\u2013110 (2019).","journal-title":"Curr. Opin. Immunol."},{"key":"470_CR157","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1172\/JCI77014","volume":"125","author":"F Tzelepis","year":"2015","unstructured":"Tzelepis, F. et al. Annexin1 regulates DC efferocytosis and cross-presentation during Mycobacterium tuberculosis infection. J. Clin. Invest. 125, 752\u2013768 (2015).","journal-title":"J. Clin. Invest."},{"key":"470_CR158","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-018-1214-5","volume":"9","author":"AC Codo","year":"2018","unstructured":"Codo, A. C. et al. Inhibition of inflammasome activation by a clinical strain of Klebsiella pneumoniae impairs efferocytosis and leads to bacterial dissemination. Cell Death Dis. 9, 1\u201314 (2018).","journal-title":"Cell Death Dis."},{"key":"470_CR159","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.4049\/jimmunol.178.4.2448","volume":"178","author":"Y Hashimoto","year":"2007","unstructured":"Hashimoto, Y., Moki, T., Takizawa, T., Shiratsuchi, A. & Nakanishi, Y. Evidence for phagocytosis of influenza virus-infected, apoptotic cells by neutrophils and macrophages in mice. J. Immunol. 178, 2448\u20132457 (2007).","journal-title":"J. Immunol."},{"key":"470_CR160","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/s41590-020-0746-x","volume":"21","author":"K Lim","year":"2020","unstructured":"Lim, K. et al. In situ neutrophil efferocytosis shapes T cell immunity to influenza infection. Nat. Immunol. 21, 1046\u20131057 (2020).","journal-title":"Nat. Immunol."},{"key":"470_CR161","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/417095a","volume":"417","author":"DC Douek","year":"2002","unstructured":"Douek, D. C. et al. HIV preferentially infects HIV-specific CD4+ T cells. Nature 417, 95\u201398 (2002).","journal-title":"Nature"},{"key":"470_CR162","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nature12940","volume":"505","author":"G Doitsh","year":"2014","unstructured":"Doitsh, G. et al. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature 505, 509\u2013514 (2014).","journal-title":"Nature"},{"key":"470_CR163","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1172\/JCI115188","volume":"87","author":"C Terai","year":"1991","unstructured":"Terai, C., Kornbluth, R., Pauza, C. D., Richman, D. D. & Carson, D. A. Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J. Clin. Invest. 87, 1710\u20131715 (1991).","journal-title":"J. Clin. Invest."},{"key":"470_CR164","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.virol.2017.12.025","volume":"515","author":"BA Chua","year":"2018","unstructured":"Chua, B. A. et al. Protein S and Gas6 induce efferocytosis of HIV-1-infected cells. Virology 515, 176\u2013190 (2018).","journal-title":"Virology"},{"key":"470_CR165","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1097\/00002030-200207050-00003","volume":"16","author":"M Larsson","year":"2002","unstructured":"Larsson, M. et al. Activation of HIV-1 specific CD4 and CD8 T cells by human dendritic cells: roles for cross-presentation and non-infectious HIV-1 virus. Aids 16, 1319\u20131329 (2002).","journal-title":"Aids"},{"key":"470_CR166","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nature13168","volume":"509","author":"MA Czuczman","year":"2014","unstructured":"Czuczman, M. A. et al. Listeria monocytogenes exploits efferocytosis to promote cell-to-cell spread. Nature 509, 230\u2013234 (2014).","journal-title":"Nature"},{"key":"470_CR167","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.chom.2017.09.003","volume":"22","author":"T Dallenga","year":"2017","unstructured":"Dallenga, T. et al. M. tuberculosis-induced necrosis of infected neutrophils promotes bacterial growth following phagocytosis by macrophages. Cell Host Microbe 22, 519\u2013530.e3 (2017). This study highlights the nature of the infecting strain and cell death modality of the host cell in M. tuberculosis infections, with implications for efferocytic clearance of bacteria.","journal-title":"Cell Host Microbe"},{"key":"470_CR168","doi-asserted-by":"publisher","first-page":"e2018","DOI":"10.1038\/cddis.2015.351","volume":"6","author":"F Ribeiro-Gomes","year":"2015","unstructured":"Ribeiro-Gomes, F. et al. Apoptotic cell clearance of Leishmania major-infected neutrophils by dendritic cells inhibits CD8+ T-cell priming in vitro by Mer tyrosine kinase-dependent signaling. Cell Death Dis. 6, e2018\u2013e2018 (2015).","journal-title":"Cell Death Dis."},{"key":"470_CR169","doi-asserted-by":"publisher","first-page":"6521","DOI":"10.4049\/jimmunol.173.11.6521","volume":"173","author":"G van Zandbergen","year":"2004","unstructured":"van Zandbergen, G. et al. Cutting edge: neutrophil granulocyte serves as a vector for Leishmania entry into macrophages. J. Immunol. 173, 6521\u20136525 (2004).","journal-title":"J. Immunol."},{"key":"470_CR170","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/35003208","volume":"403","author":"CG Freire-de-Lima","year":"2000","unstructured":"Freire-de-Lima, C. G. et al. Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages. Nature 403, 199\u2013203 (2000).","journal-title":"Nature"},{"key":"470_CR171","doi-asserted-by":"publisher","first-page":"4823","DOI":"10.2147\/IJN.S132762","volume":"12","author":"B Sims","year":"2017","unstructured":"Sims, B. et al. Role of TIM-4 in exosome-dependent entry of HIV-1 into human immune cells. Int. J. Nanomed. 12, 4823 (2017).","journal-title":"Int. J. Nanomed."},{"key":"470_CR172","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006983","volume":"13","author":"B Brunton","year":"2019","unstructured":"Brunton, B. et al. TIM-1 serves as a receptor for Ebola virus in vivo, enhancing viremia and pathogenesis. PLoS Negl. Trop. Dis. 13, e0006983 (2019).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"470_CR173","doi-asserted-by":"publisher","first-page":"8426","DOI":"10.1073\/pnas.1019030108","volume":"108","author":"AS Kondratowicz","year":"2011","unstructured":"Kondratowicz, A. S. et al. T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus. Proc. Natl Acad. Sci. USA 108, 8426\u20138431 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"470_CR174","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.chom.2012.08.009","volume":"12","author":"L Meertens","year":"2012","unstructured":"Meertens, L. et al. The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry. Cell Host Microbe 12, 544\u2013557 (2012).","journal-title":"Cell Host Microbe"},{"key":"470_CR175","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.tim.2019.10.004","volume":"28","author":"JP Evans","year":"2020","unstructured":"Evans, J. P. & Liu, S.-L. Multifaceted roles of TIM-family proteins in virus\u2013host interactions. Trends Microbiol. 28, 224\u2013235 (2020).","journal-title":"Trends Microbiol."},{"key":"470_CR176","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.chom.2011.03.012","volume":"9","author":"K Morizono","year":"2011","unstructured":"Morizono, K. et al. The soluble serum protein Gas6 bridges virion envelope phosphatidylserine to the TAM receptor tyrosine kinase Axl to mediate viral entry. Cell Host Microbe 9, 286\u2013298 (2011).","journal-title":"Cell Host Microbe"},{"key":"470_CR177","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.virol.2021.04.013","volume":"560","author":"D-H Song","year":"2021","unstructured":"Song, D.-H. et al. Development of a blocker of the universal phosphatidylserine- and phosphatidylethanolamine-dependent viral entry pathways. Virology 560, 17\u201333 (2021).","journal-title":"Virology"},{"key":"470_CR178","doi-asserted-by":"publisher","first-page":"E3699","DOI":"10.1073\/pnas.1404851111","volume":"111","author":"M Li","year":"2014","unstructured":"Li, M. et al. TIM-family proteins inhibit HIV-1 release. Proc. Natl Acad. Sci. USA 111, E3699\u2013E3707 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"470_CR179","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.jcmgh.2015.02.003","volume":"1","author":"S Das","year":"2015","unstructured":"Das, S. et al. ELMO1 has an essential role in the internalization of Salmonella Typhimurium into enteric macrophages that impacts disease outcome. Cell. Mol. Gastroenterol. Hepatol. 1, 311\u2013324 (2015).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"470_CR180","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1093\/infdis\/jix528","volume":"216","author":"A Sarkar","year":"2017","unstructured":"Sarkar, A. et al. ELMO1 regulates autophagy induction and bacterial clearance during enteric infection. J. Infect. Dis. 216, 1655\u20131666 (2017).","journal-title":"J. Infect. Dis."},{"key":"470_CR181","doi-asserted-by":"publisher","first-page":"ra14","DOI":"10.1126\/scisignal.aac6250","volume":"9","author":"EA Billings","year":"2016","unstructured":"Billings, E. A. et al. The adhesion GPCR BAI1 mediates macrophage ROS production and microbicidal activity against Gram-negative bacteria. Sci. Signal. 9, ra14 (2016).","journal-title":"Sci. Signal."},{"key":"470_CR182","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3389\/fimmu.2019.00421","volume":"10","author":"O Tamgue","year":"2019","unstructured":"Tamgue, O. et al. Differential targeting of c-Maf, Bach-1, and Elmo-1 by microRNA-143 and microRNA-365 promotes the intracellular growth of Mycobacterium tuberculosis in alternatively IL-4\/IL-13 activated macrophages. Front. Immunol. 10, 421 (2019).","journal-title":"Front. Immunol."},{"key":"470_CR183","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO;2-K","volume":"46","author":"I Baumann","year":"2002","unstructured":"Baumann, I. et al. Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum. 46, 191\u2013201 (2002).","journal-title":"Arthritis Rheum."},{"key":"470_CR184","doi-asserted-by":"publisher","first-page":"33335","DOI":"10.1074\/jbc.M111.263020","volume":"286","author":"E Thorp","year":"2011","unstructured":"Thorp, E. et al. Shedding of the Mer tyrosine kinase receptor is mediated by ADAM17 protein through a pathway involving reactive oxygen species, protein kinase C\u03b4, and p38 mitogen-activated protein kinase (MAPK). J. Biol. Chem. 286, 33335\u201333344 (2011).","journal-title":"J. Biol. Chem."},{"key":"470_CR185","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.clim.2016.05.011","volume":"169","author":"JJ Orme","year":"2016","unstructured":"Orme, J. J. et al. Heightened cleavage of Axl receptor tyrosine kinase by ADAM metalloproteases may contribute to disease pathogenesis in SLE. Clin. Immunol. 169, 58\u201368 (2016).","journal-title":"Clin. Immunol."},{"key":"470_CR186","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12969-015-0007-y","volume":"13","author":"L Ballantine","year":"2015","unstructured":"Ballantine, L. et al. Increased soluble phagocytic receptors sMer, sTyro3 and sAxl and reduced phagocytosis in juvenile-onset systemic lupus erythematosus. Pediatr. Rheumatol. 13, 1\u201311 (2015).","journal-title":"Pediatr. Rheumatol."},{"key":"470_CR187","doi-asserted-by":"publisher","first-page":"4369","DOI":"10.4049\/jimmunol.1101749","volume":"187","author":"LT Roumenina","year":"2011","unstructured":"Roumenina, L. T. et al. Functional complement C1q abnormality leads to impaired immune complexes and apoptotic cell clearance. J. Immunol. 187, 4369\u20134373 (2011).","journal-title":"J. Immunol."},{"key":"470_CR188","first-page":"1128","volume":"21","author":"K Sullivan","year":"1994","unstructured":"Sullivan, K., Petri, M., Schmeckpeper, B., McLean, R. & Winkelstein, J. Prevalence of a mutation causing C2 deficiency in systemic lupus erythematosus. J. Rheumatol. 21, 1128\u20131133 (1994).","journal-title":"J. Rheumatol."},{"key":"470_CR189","doi-asserted-by":"publisher","first-page":"955","DOI":"10.4049\/jimmunol.2100532","volume":"208","author":"AM Jorge","year":"2021","unstructured":"Jorge, A. M. et al. SCARF1-induced efferocytosis plays an immunomodulatory role in humans, and autoantibodies targeting SCARF1 are produced in patients with systemic lupus erythematosus. J. Immunol. 208, 955\u2013967 (2021).","journal-title":"J. Immunol."},{"key":"470_CR190","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201138","volume":"218","author":"J Hartl","year":"2021","unstructured":"Hartl, J. et al. Autoantibody-mediated impairment of DNASE1L3 activity in sporadic systemic lupus erythematosus. J. Exp. Med. 218, e20201138 (2021).","journal-title":"J. Exp. Med."},{"key":"470_CR191","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1073\/pnas.1720732115","volume":"115","author":"M Kawano","year":"2018","unstructured":"Kawano, M. & Nagata, S. Lupus-like autoimmune disease caused by a lack of Xkr8, a caspase-dependent phospholipid scramblase. Proc. Natl Acad. Sci. USA 115, 2132\u20132137 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"470_CR192","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.immuni.2009.06.018","volume":"31","author":"A Noelia","year":"2009","unstructured":"Noelia, A. et al. Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity 31, 245\u2013258 (2009). This important study highlights the role of nuclear receptors in anti-inflammatory effects of efferocytosis and plausible therapeutic advantages of targeting the pathway.","journal-title":"Immunity"},{"key":"470_CR193","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.4049\/jimmunol.0804341","volume":"183","author":"W Zhao","year":"2009","unstructured":"Zhao, W. et al. The peroxisome proliferator-activated receptor \u03b3 agonist pioglitazone improves cardiometabolic risk and renal inflammation in murine lupus. J. Immunol. 183, 2729\u20132740 (2009).","journal-title":"J. Immunol."},{"key":"470_CR194","doi-asserted-by":"publisher","first-page":"120389","DOI":"10.1016\/j.biomaterials.2020.120389","volume":"267","author":"YY Lee","year":"2021","unstructured":"Lee, Y. Y. et al. Long-acting nanoparticulate DNase-1 for effective suppression of SARS-CoV-2-mediated neutrophil activities and cytokine storm. Biomaterials 267, 120389 (2021).","journal-title":"Biomaterials"},{"key":"470_CR195","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jaut.2018.06.001","volume":"93","author":"Y Zhen","year":"2018","unstructured":"Zhen, Y., Lee, I. J., Finkelman, F. D. & Shao, W.-H. Targeted inhibition of Axl receptor tyrosine kinase ameliorates anti-GBM-induced lupus-like nephritis. J. Autoimmun. 93, 37\u201344 (2018).","journal-title":"J. Autoimmun."},{"key":"470_CR196","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5264195","author":"L Navarini","year":"2018","unstructured":"Navarini, L. et al. Role of the specialized proresolving mediator resolvin D1 in systemic lupus erythematosus: preliminary results. J. Immunol. Res. https:\/\/doi.org\/10.1155\/2018\/5264195 (2018).","journal-title":"J. Immunol. Res."},{"key":"470_CR197","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009539","volume":"5","author":"S Khanna","year":"2010","unstructured":"Khanna, S. et al. Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice. PLoS ONE 5, e9539 (2010).","journal-title":"PLoS ONE"},{"key":"470_CR198","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1161\/CIRCRESAHA.109.199570","volume":"105","author":"S Li","year":"2009","unstructured":"Li, S. et al. Defective phagocytosis of apoptotic cells by macrophages in atherosclerotic lesions of ob\/ob mice and reversal by a fish oil diet. Circ. Res. 105, 1072\u20131082 (2009).","journal-title":"Circ. Res."},{"key":"470_CR199","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"SS Babu","year":"2016","unstructured":"Babu, S. S. et al. microRNA-126 overexpression rescues diabetes-induced impairment in efferocytosis of apoptotic cardiomyocytes. Sci. Rep. 6, 1\u201312 (2016).","journal-title":"Sci. Rep."},{"key":"470_CR200","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.bbadis.2018.10.005","volume":"1865","author":"B Luo","year":"2019","unstructured":"Luo, B., Wang, Z., Zhang, Z., Shen, Z. & Zhang, Z. The deficiency of macrophage erythropoietin signaling contributes to delayed acute inflammation resolution in diet-induced obese mice. Biochim. Biophys. Acta 1865, 339\u2013349 (2019).","journal-title":"Biochim. Biophys. Acta"},{"key":"470_CR201","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.immuni.2016.01.002","volume":"44","author":"B Luo","year":"2016","unstructured":"Luo, B. et al. Erythropoeitin signaling in macrophages promotes dying cell clearance and immune tolerance. Immunity 44, 287\u2013302 (2016). This study highlights the role of S1P\u2013EPO signalling in efferocytosis.","journal-title":"Immunity"},{"key":"470_CR202","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1039\/C5BM00629E","volume":"4","author":"F Zhou","year":"2016","unstructured":"Zhou, F. et al. Targeted delivery of microRNA-126 to vascular endothelial cells via REDV peptide modified PEG-trimethyl chitosan. Biomater. Sci. 4, 849\u2013856 (2016).","journal-title":"Biomater. Sci."},{"key":"470_CR203","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.chom.2012.06.010","volume":"12","author":"CJ Martin","year":"2012","unstructured":"Martin, C. J. et al. Efferocytosis is an innate antibacterial mechanism. Cell Host Microbe 12, 289\u2013300 (2012). This work introduces the concept of the role of efferocytosis as a potential anti-bacterial mechanism; see also ref.163.","journal-title":"Cell Host Microbe"},{"key":"470_CR204","first-page":"14309","volume":"10","author":"SA Harrison","year":"2021","unstructured":"Harrison, S. A. et al. Safety, tolerability, and biologic activity of AXA1125 and AXA1957 in subjects with nonalcoholic fatty liver disease. ACG 10, 14309 (2021).","journal-title":"ACG"},{"key":"470_CR205","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/ansa.202000178","volume":"2","author":"P Phapale","year":"2021","unstructured":"Phapale, P. Pharmaco-metabolomics opportunities in drug development and clinical research. Anal. Sci. Adv. 2, 611\u2013616 (2021).","journal-title":"Anal. Sci. Adv."},{"key":"470_CR206","first-page":"137","volume":"29","author":"D Bohan","year":"2021","unstructured":"Bohan, D. et al. Targeting the receptor AXL by bemcentinib prevents SARS-CoV-2 infection. Top. Antivir. Med. 29, 137\u2013138 (2021).","journal-title":"Top. Antivir. Med."},{"key":"470_CR207","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009743","volume":"17","author":"D Bohan","year":"2021","unstructured":"Bohan, D. et al. Phosphatidylserine receptors enhance SARS-CoV-2 infection. PLoS Pathog. 17, e1009743 (2021).","journal-title":"PLoS Pathog."},{"key":"470_CR208","doi-asserted-by":"publisher","first-page":"16183","DOI":"10.18632\/oncotarget.3952","volume":"6","author":"M Vouri","year":"2015","unstructured":"Vouri, M., An, Q., Birt, M., Pilkington, G. J. & Hafizi, S. Small molecule inhibition of Axl receptor tyrosine kinase potently suppresses multiple malignant properties of glioma cells. Oncotarget 6, 16183 (2015).","journal-title":"Oncotarget"},{"key":"470_CR209","first-page":"1466","volume":"8","author":"F Chen","year":"2018","unstructured":"Chen, F., Song, Q. & Yu, Q. Axl inhibitor R428 induces apoptosis of cancer cells by blocking lysosomal acidification and recycling independent of Axl inhibition. Am. J. Cancer Res. 8, 1466 (2018).","journal-title":"Am. J. Cancer Res."},{"key":"470_CR210","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.3390\/ijms20133253","volume":"20","author":"SM Woo","year":"2019","unstructured":"Woo, S. M. et al. Axl inhibitor R428 enhances TRAIL-mediated apoptosis through downregulation of c-FLIP and survivin expression in renal carcinoma. Int. J. Mol. Sci. 20, 3253 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"470_CR211","doi-asserted-by":"crossref","unstructured":"Felip, E. et al. A phase II study of bemcentinib (BGB324), a first-in-class highly selective AXL inhibitor, with pembrolizumab in pts with advanced NSCLC: OS for stage I and preliminary stage II efficacy [abstract 9098]. J. Clin. Oncol. 37, no. 15_suppl 2630\u20132630 (2019).","DOI":"10.1200\/JCO.2019.37.15_suppl.9098"},{"key":"470_CR212","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00280-014-2481-1","volume":"74","author":"M Mita","year":"2014","unstructured":"Mita, M. et al. Phase 1B study of amuvatinib in combination with five standard cancer therapies in adults with advanced solid tumors. Cancer Chemother. Pharmacol. 74, 195\u2013204 (2014).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"470_CR213","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00280-012-2019-3","volume":"71","author":"R Tibes","year":"2013","unstructured":"Tibes, R. et al. A phase I, first-in-human dose-escalation study of amuvatinib, a multi-targeted tyrosine kinase inhibitor, in patients with advanced solid tumors. Cancer Chemother. Pharmacol. 71, 463\u2013471 (2013).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"470_CR214","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1038\/onc.2013.57","volume":"33","author":"MK Asiedu","year":"2014","unstructured":"Asiedu, M. K. et al. AXL induces epithelial-to-mesenchymal transition and regulates the function of breast cancer stem cells. Oncogene 33, 1316\u20131324 (2014).","journal-title":"Oncogene"},{"key":"470_CR215","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ejphar.2017.11.016","volume":"818","author":"S Aveic","year":"2018","unstructured":"Aveic, S. et al. TP-0903 inhibits neuroblastoma cell growth and enhances the sensitivity to conventional chemotherapy. Eur. J. Pharmacol. 818, 435\u2013448 (2018).","journal-title":"Eur. J. Pharmacol."},{"key":"470_CR216","doi-asserted-by":"publisher","unstructured":"Sarantopoulos, J. et al. A phase 1a \/ 1b first-in-human, open-label, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of oral TP-0903, a potent inhibitor of AXL kinase, administered daily for 21 days to patients with advanced solid tumors [abstract TPS2612]. J. Clin. Oncol. https:\/\/doi.org\/10.1200\/JCO.2018.36.15_suppl.TPS2612 (2018).","DOI":"10.1200\/JCO.2018.36.15_suppl.TPS2612"},{"key":"470_CR217","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.140169","volume":"5","author":"JY Jeon","year":"2020","unstructured":"Jeon, J. Y. et al. TP-0903 is active in models of drug-resistant acute myeloid leukemia. JCI Insight 5, e140169 (2020).","journal-title":"JCI Insight"},{"key":"470_CR218","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.3109\/10428194.2015.1102243","volume":"57","author":"V Patel","year":"2016","unstructured":"Patel, V., Keating, M. J., Wierda, W. G. & Gandhi, V. Preclinical combination of TP-0903, an AXL inhibitor and B-PAC-1, a procaspase-activating compound with ibrutinib in chronic lymphocytic leukemia. Leuk. Lymphoma 57, 1494\u20131497 (2016).","journal-title":"Leuk. Lymphoma"},{"key":"470_CR219","doi-asserted-by":"publisher","first-page":"107577","DOI":"10.1016\/j.pharmthera.2020.107577","volume":"213","author":"JM Huelse","year":"2020","unstructured":"Huelse, J. M., Fridlyand, D. M., Earp, S., DeRyckere, D. & Graham, D. K. MERTK in cancer therapy: targeting the receptor tyrosine kinase in tumor cells and the immune system. Pharmacol. Ther. 213, 107577 (2020).","journal-title":"Pharmacol. Ther."},{"key":"470_CR220","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00439-016-1637-y","volume":"135","author":"NG Ghazi","year":"2016","unstructured":"Ghazi, N. G. et al. Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial. Hum. Genet. 135, 327\u2013343 (2016).","journal-title":"Hum. Genet."},{"key":"470_CR221","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1089\/humc.2013.037","volume":"24","author":"TJ Conlon","year":"2013","unstructured":"Conlon, T. J. et al. Preclinical potency and safety studies of an AAV2-mediated gene therapy vector for the treatment of MERTK associated retinitis pigmentosa. Hum. Gene. Ther. Clin. Dev. 24, 23\u201328 (2013).","journal-title":"Hum. Gene. Ther. Clin. Dev."},{"key":"470_CR222","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/978-0-387-74904-4_13","volume":"613","author":"JJ Alexander","year":"2008","unstructured":"Alexander, J. J. & Hauswirth, W. W. Adeno-associated viral vectors and the retina. Adv. Exp. Med. Biol. 613, 121\u2013128 (2008).","journal-title":"Adv. Exp. Med. Biol."},{"key":"470_CR223","doi-asserted-by":"crossref","unstructured":"Fisher, G. A. et al. A phase Ib\/II study of the anti-CD47 antibody magrolimab with cetuximab in solid tumor and colorectal cancer patients [abstract 114]. J. Clin. Oncol. 38, no. 4_suppl 114\u2013114 (2020).","DOI":"10.1200\/JCO.2020.38.4_suppl.114"},{"key":"470_CR224","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","volume":"20","author":"MZ Tay","year":"2020","unstructured":"Tay, M. Z., Poh, C. M., R\u00e9nia, L., MacAry, P. A. & Ng, L. F. The trinity of COVID-19: immunity, inflammation and intervention. Nat. Rev. Immunol. 20, 363\u2013374 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"470_CR225","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.chom.2020.04.009","volume":"27","author":"EJ Giamarellos-Bourboulis","year":"2020","unstructured":"Giamarellos-Bourboulis, E. J. et al. Complex immune dysregulation in COVID-19 patients with severe respiratory failure. Cell Host Microbe 27, 992\u20131000.e3 (2020).","journal-title":"Cell Host Microbe"},{"key":"470_CR226","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.cell.2020.08.001","volume":"182","author":"J Schulte-Schrepping","year":"2020","unstructured":"Schulte-Schrepping, J. et al. Severe COVID-19 is marked by a dysregulated myeloid cell compartment. Cell 182, 1419\u20131440.e23 (2020).","journal-title":"Cell"},{"key":"470_CR227","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1002\/jmv.25819","volume":"92","author":"FA Lagunas\u2010Rangel","year":"2020","unstructured":"Lagunas-Rangel, F. A. Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis. J. Med. Virol. 92, 1733\u20131734 (2020).","journal-title":"J. Med. Virol."},{"key":"470_CR228","doi-asserted-by":"publisher","first-page":"1702590","DOI":"10.1183\/13993003.02590-2017","volume":"52","author":"M Gr\u00e9goire","year":"2018","unstructured":"Gr\u00e9goire, M. et al. Impaired efferocytosis and neutrophil extracellular trap clearance by macrophages in ARDS. Eur. Respir. J. 52, 1702590 (2018).","journal-title":"Eur. Respir. J."},{"key":"470_CR229","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1182\/blood.2020007008","volume":"136","author":"EA Middleton","year":"2020","unstructured":"Middleton, E. A. et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood 136, 1169\u20131179 (2020).","journal-title":"Blood"},{"key":"470_CR230","doi-asserted-by":"publisher","DOI":"10.1101\/2021.02.18.21251504","author":"D dos-Santos","year":"2021","unstructured":"dos-Santos, D. et al. Efferocytosis of SARS-CoV-2-infected dying cells impairs macrophage anti-inflammatory programming and continual clearance of apoptotic cells. medRxiv https:\/\/doi.org\/10.1101\/2021.02.18.21251504 (2021).","journal-title":"medRxiv"},{"key":"470_CR231","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41586-021-03491-6","volume":"594","author":"L Braga","year":"2021","unstructured":"Braga, L. et al. Drugs that inhibit TMEM16 proteins block SARS-CoV-2 Spike-induced syncytia. Nature 594, 88\u201393 (2021). This important study highlights the role of TMEM16 PS scramblase(s) in SARS-CoV-2 infection.","journal-title":"Nature"},{"key":"470_CR232","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.cytogfr.2022.01.002","volume":"63","author":"S Dutta","year":"2022","unstructured":"Dutta, S., Mukherjee, A. & Nongthomba, U. Before the \u201ccytokine storm\u201d: boosting efferocytosis as an effective strategy against SARS-CoV-2 infection and associated complications. Cytokine Growth Factor Rev. 63, 108\u2013118 (2022).","journal-title":"Cytokine Growth Factor Rev."}],"container-title":["Nature Reviews Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41573-022-00470-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41573-022-00470-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41573-022-00470-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T18:02:51Z","timestamp":1733940171000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41573-022-00470-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":232,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["470"],"URL":"https:\/\/doi.org\/10.1038\/s41573-022-00470-y","relation":{},"ISSN":["1474-1776","1474-1784"],"issn-type":[{"value":"1474-1776","type":"print"},{"value":"1474-1784","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,1]]},"assertion":[{"value":"12 April 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}